China SXT Pharmaceuticals SXTC
NASDAQ SXTC
$0.07 +0.01 (+11.79%)
At close: Oct 21, 2026 · 4:00 PM EDT

China SXT Pharmaceuticals (SXTC) Enterprise Value (2023 - 2026)

Updated

China SXT Pharmaceuticals' Enterprise Value came in at -$26.41 million for fiscal Q4 2026 (quarter ended Mar 31, 2026), compared with $374.8 million a year earlier.

Analysis

China SXT Pharmaceuticals (SXTC) Enterprise Value (2023 - 2026) Analysis & Trends

Going back to fiscal Q2 2024, China SXT Pharmaceuticals' Enterprise Value data covers 6 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 China SXT Pharmaceuticals 603.22 -85.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -26.57 Mn
Sep 30, 2025 226.07 Mn
Mar 31, 2025 374.80 Mn
Sep 30, 2024 96.44 Mn
Mar 31, 2024 252.49 Mn
Sep 30, 2023 472.77 Mn
API Access

China SXT Pharmaceuticals Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=SXTC&period=max&api_key=YOUR_API_KEY